Maze Therapeutics, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Maze Therapeutics, Inc. now
Current reporting with the operating signal separated from the noise.
Can Maze Therapeutics, Inc. (MAZE) climb 120.48% to reach the level Wall Street analysts expect?
The story matters when it changes Maze Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Truist Updates Maze Therapeutics, Inc. (MAZE) Model for Share Count and Warrant Impact
Investors are testing whether Maze Therapeutics, Inc.’s operating performance supports its strategy and valuation.
Watch next: official volume, pricing, inventory and segment margin.Maze Therapeutics, Inc. (MAZE) Presents at Jefferies London Healthcare Conference 2025 Prepared Remarks Transcript
The story matters when it changes Maze Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Maze Therapeutics, Inc. (MAZE) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript
The story matters when it changes Maze Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
The story matters when it changes Maze Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest MAZE filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Maze Therapeutics, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →